nodes	percent_of_prediction	percent_of_DWPC	metapath
Valganciclovir—Ill-defined disorder—Betamethasone—psoriatic arthritis	0.0013	0.0013	CcSEcCtD
Valganciclovir—Ill-defined disorder—Dexamethasone—psoriatic arthritis	0.0013	0.0013	CcSEcCtD
Valganciclovir—Discomfort—Triamcinolone—psoriatic arthritis	0.0013	0.0013	CcSEcCtD
Valganciclovir—Discomfort—Methylprednisolone—psoriatic arthritis	0.00129	0.00129	CcSEcCtD
Valganciclovir—Dry mouth—Triamcinolone—psoriatic arthritis	0.00128	0.00128	CcSEcCtD
Valganciclovir—Renal failure—Methotrexate—psoriatic arthritis	0.00128	0.00128	CcSEcCtD
Valganciclovir—Stomatitis—Methotrexate—psoriatic arthritis	0.00127	0.00127	CcSEcCtD
Valganciclovir—Angiopathy—Prednisone—psoriatic arthritis	0.00127	0.00127	CcSEcCtD
Valganciclovir—Confusional state—Methylprednisolone—psoriatic arthritis	0.00126	0.00126	CcSEcCtD
Valganciclovir—Immune system disorder—Prednisone—psoriatic arthritis	0.00126	0.00126	CcSEcCtD
Valganciclovir—Malaise—Dexamethasone—psoriatic arthritis	0.00126	0.00126	CcSEcCtD
Valganciclovir—Malaise—Betamethasone—psoriatic arthritis	0.00126	0.00126	CcSEcCtD
Valganciclovir—Anaphylactic shock—Triamcinolone—psoriatic arthritis	0.00126	0.00126	CcSEcCtD
Valganciclovir—Oedema—Triamcinolone—psoriatic arthritis	0.00126	0.00126	CcSEcCtD
Valganciclovir—Vertigo—Betamethasone—psoriatic arthritis	0.00126	0.00126	CcSEcCtD
Valganciclovir—Vertigo—Dexamethasone—psoriatic arthritis	0.00126	0.00126	CcSEcCtD
Valganciclovir—Anaphylactic shock—Methylprednisolone—psoriatic arthritis	0.00125	0.00125	CcSEcCtD
Valganciclovir—Arrhythmia—Prednisone—psoriatic arthritis	0.00125	0.00125	CcSEcCtD
Valganciclovir—Infection—Triamcinolone—psoriatic arthritis	0.00125	0.00125	CcSEcCtD
Valganciclovir—Infection—Methylprednisolone—psoriatic arthritis	0.00125	0.00125	CcSEcCtD
Valganciclovir—Haematuria—Methotrexate—psoriatic arthritis	0.00124	0.00124	CcSEcCtD
Valganciclovir—Insomnia—Prednisolone—psoriatic arthritis	0.00124	0.00124	CcSEcCtD
Valganciclovir—Alopecia—Prednisone—psoriatic arthritis	0.00124	0.00124	CcSEcCtD
Valganciclovir—Hepatobiliary disease—Methotrexate—psoriatic arthritis	0.00123	0.00123	CcSEcCtD
Valganciclovir—Nervous system disorder—Methylprednisolone—psoriatic arthritis	0.00123	0.00123	CcSEcCtD
Valganciclovir—Paraesthesia—Prednisolone—psoriatic arthritis	0.00123	0.00123	CcSEcCtD
Valganciclovir—Tachycardia—Triamcinolone—psoriatic arthritis	0.00123	0.00123	CcSEcCtD
Valganciclovir—Mental disorder—Prednisone—psoriatic arthritis	0.00122	0.00122	CcSEcCtD
Valganciclovir—Tachycardia—Methylprednisolone—psoriatic arthritis	0.00122	0.00122	CcSEcCtD
Valganciclovir—Skin disorder—Methylprednisolone—psoriatic arthritis	0.00122	0.00122	CcSEcCtD
Valganciclovir—Malnutrition—Prednisone—psoriatic arthritis	0.00122	0.00122	CcSEcCtD
Valganciclovir—Hyperhidrosis—Triamcinolone—psoriatic arthritis	0.00122	0.00122	CcSEcCtD
Valganciclovir—Hyperhidrosis—Methylprednisolone—psoriatic arthritis	0.00121	0.00121	CcSEcCtD
Valganciclovir—Convulsion—Dexamethasone—psoriatic arthritis	0.00121	0.00121	CcSEcCtD
Valganciclovir—Convulsion—Betamethasone—psoriatic arthritis	0.00121	0.00121	CcSEcCtD
Valganciclovir—Hypertension—Dexamethasone—psoriatic arthritis	0.00121	0.00121	CcSEcCtD
Valganciclovir—Hypertension—Betamethasone—psoriatic arthritis	0.00121	0.00121	CcSEcCtD
Valganciclovir—Anxiety—Dexamethasone—psoriatic arthritis	0.00119	0.00119	CcSEcCtD
Valganciclovir—Anxiety—Betamethasone—psoriatic arthritis	0.00119	0.00119	CcSEcCtD
Valganciclovir—Discomfort—Betamethasone—psoriatic arthritis	0.00118	0.00118	CcSEcCtD
Valganciclovir—Discomfort—Dexamethasone—psoriatic arthritis	0.00118	0.00118	CcSEcCtD
Valganciclovir—Haemoglobin—Methotrexate—psoriatic arthritis	0.00117	0.00117	CcSEcCtD
Valganciclovir—Hypotension—Methylprednisolone—psoriatic arthritis	0.00117	0.00117	CcSEcCtD
Valganciclovir—Pain—Prednisolone—psoriatic arthritis	0.00117	0.00117	CcSEcCtD
Valganciclovir—Haemorrhage—Methotrexate—psoriatic arthritis	0.00117	0.00117	CcSEcCtD
Valganciclovir—Hepatitis—Methotrexate—psoriatic arthritis	0.00117	0.00117	CcSEcCtD
Valganciclovir—Pharyngitis—Methotrexate—psoriatic arthritis	0.00116	0.00116	CcSEcCtD
Valganciclovir—Urinary tract disorder—Methotrexate—psoriatic arthritis	0.00115	0.00115	CcSEcCtD
Valganciclovir—Vision blurred—Prednisone—psoriatic arthritis	0.00115	0.00115	CcSEcCtD
Valganciclovir—Urethral disorder—Methotrexate—psoriatic arthritis	0.00115	0.00115	CcSEcCtD
Valganciclovir—Musculoskeletal discomfort—Triamcinolone—psoriatic arthritis	0.00115	0.00115	CcSEcCtD
Valganciclovir—Musculoskeletal discomfort—Methylprednisolone—psoriatic arthritis	0.00114	0.00114	CcSEcCtD
Valganciclovir—Anaphylactic shock—Dexamethasone—psoriatic arthritis	0.00114	0.00114	CcSEcCtD
Valganciclovir—Oedema—Betamethasone—psoriatic arthritis	0.00114	0.00114	CcSEcCtD
Valganciclovir—Anaphylactic shock—Betamethasone—psoriatic arthritis	0.00114	0.00114	CcSEcCtD
Valganciclovir—Oedema—Dexamethasone—psoriatic arthritis	0.00114	0.00114	CcSEcCtD
Valganciclovir—Insomnia—Triamcinolone—psoriatic arthritis	0.00114	0.00114	CcSEcCtD
Valganciclovir—Insomnia—Methylprednisolone—psoriatic arthritis	0.00113	0.00113	CcSEcCtD
Valganciclovir—Infection—Dexamethasone—psoriatic arthritis	0.00113	0.00113	CcSEcCtD
Valganciclovir—Infection—Betamethasone—psoriatic arthritis	0.00113	0.00113	CcSEcCtD
Valganciclovir—Ill-defined disorder—Prednisone—psoriatic arthritis	0.00113	0.00113	CcSEcCtD
Valganciclovir—Paraesthesia—Triamcinolone—psoriatic arthritis	0.00113	0.00113	CcSEcCtD
Valganciclovir—Feeling abnormal—Prednisolone—psoriatic arthritis	0.00113	0.00113	CcSEcCtD
Valganciclovir—Paraesthesia—Methylprednisolone—psoriatic arthritis	0.00113	0.00113	CcSEcCtD
Valganciclovir—Visual impairment—Methotrexate—psoriatic arthritis	0.00113	0.00113	CcSEcCtD
Valganciclovir—Anaemia—Prednisone—psoriatic arthritis	0.00112	0.00112	CcSEcCtD
Valganciclovir—Dyspnoea—Triamcinolone—psoriatic arthritis	0.00112	0.00112	CcSEcCtD
Valganciclovir—Nervous system disorder—Dexamethasone—psoriatic arthritis	0.00112	0.00112	CcSEcCtD
Valganciclovir—Nervous system disorder—Betamethasone—psoriatic arthritis	0.00112	0.00112	CcSEcCtD
Valganciclovir—Agitation—Prednisone—psoriatic arthritis	0.00112	0.00112	CcSEcCtD
Valganciclovir—Thrombocytopenia—Betamethasone—psoriatic arthritis	0.00112	0.00112	CcSEcCtD
Valganciclovir—Thrombocytopenia—Dexamethasone—psoriatic arthritis	0.00112	0.00112	CcSEcCtD
Valganciclovir—Tachycardia—Dexamethasone—psoriatic arthritis	0.00111	0.00111	CcSEcCtD
Valganciclovir—Tachycardia—Betamethasone—psoriatic arthritis	0.00111	0.00111	CcSEcCtD
Valganciclovir—Dyspepsia—Triamcinolone—psoriatic arthritis	0.00111	0.00111	CcSEcCtD
Valganciclovir—Dyspepsia—Methylprednisolone—psoriatic arthritis	0.0011	0.0011	CcSEcCtD
Valganciclovir—Hyperhidrosis—Betamethasone—psoriatic arthritis	0.0011	0.0011	CcSEcCtD
Valganciclovir—Hyperhidrosis—Dexamethasone—psoriatic arthritis	0.0011	0.0011	CcSEcCtD
Valganciclovir—Malaise—Prednisone—psoriatic arthritis	0.0011	0.0011	CcSEcCtD
Valganciclovir—Vertigo—Prednisone—psoriatic arthritis	0.00109	0.00109	CcSEcCtD
Valganciclovir—Eye disorder—Methotrexate—psoriatic arthritis	0.00109	0.00109	CcSEcCtD
Valganciclovir—Tinnitus—Methotrexate—psoriatic arthritis	0.00109	0.00109	CcSEcCtD
Valganciclovir—Anorexia—Dexamethasone—psoriatic arthritis	0.00109	0.00109	CcSEcCtD
Valganciclovir—Anorexia—Betamethasone—psoriatic arthritis	0.00109	0.00109	CcSEcCtD
Valganciclovir—Urticaria—Prednisolone—psoriatic arthritis	0.00109	0.00109	CcSEcCtD
Valganciclovir—Cardiac disorder—Methotrexate—psoriatic arthritis	0.00108	0.00108	CcSEcCtD
Valganciclovir—Fatigue—Triamcinolone—psoriatic arthritis	0.00108	0.00108	CcSEcCtD
Valganciclovir—Fatigue—Methylprednisolone—psoriatic arthritis	0.00108	0.00108	CcSEcCtD
Valganciclovir—Pain—Triamcinolone—psoriatic arthritis	0.00108	0.00108	CcSEcCtD
Valganciclovir—Hypotension—Dexamethasone—psoriatic arthritis	0.00107	0.00107	CcSEcCtD
Valganciclovir—Hypotension—Betamethasone—psoriatic arthritis	0.00107	0.00107	CcSEcCtD
Valganciclovir—Angiopathy—Methotrexate—psoriatic arthritis	0.00106	0.00106	CcSEcCtD
Valganciclovir—Immune system disorder—Methotrexate—psoriatic arthritis	0.00106	0.00106	CcSEcCtD
Valganciclovir—Convulsion—Prednisone—psoriatic arthritis	0.00105	0.00105	CcSEcCtD
Valganciclovir—Mediastinal disorder—Methotrexate—psoriatic arthritis	0.00105	0.00105	CcSEcCtD
Valganciclovir—Hypertension—Prednisone—psoriatic arthritis	0.00105	0.00105	CcSEcCtD
Valganciclovir—Chills—Methotrexate—psoriatic arthritis	0.00105	0.00105	CcSEcCtD
Valganciclovir—Musculoskeletal discomfort—Betamethasone—psoriatic arthritis	0.00104	0.00104	CcSEcCtD
Valganciclovir—Musculoskeletal discomfort—Dexamethasone—psoriatic arthritis	0.00104	0.00104	CcSEcCtD
Valganciclovir—Arthralgia—Prednisone—psoriatic arthritis	0.00104	0.00104	CcSEcCtD
Valganciclovir—Feeling abnormal—Triamcinolone—psoriatic arthritis	0.00104	0.00104	CcSEcCtD
Valganciclovir—Feeling abnormal—Methylprednisolone—psoriatic arthritis	0.00103	0.00103	CcSEcCtD
Valganciclovir—Anxiety—Prednisone—psoriatic arthritis	0.00103	0.00103	CcSEcCtD
Valganciclovir—Alopecia—Methotrexate—psoriatic arthritis	0.00103	0.00103	CcSEcCtD
Valganciclovir—Insomnia—Dexamethasone—psoriatic arthritis	0.00103	0.00103	CcSEcCtD
Valganciclovir—Insomnia—Betamethasone—psoriatic arthritis	0.00103	0.00103	CcSEcCtD
Valganciclovir—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriatic arthritis	0.00103	0.00103	CcSEcCtD
Valganciclovir—Gastrointestinal pain—Methylprednisolone—psoriatic arthritis	0.00103	0.00103	CcSEcCtD
Valganciclovir—Paraesthesia—Betamethasone—psoriatic arthritis	0.00102	0.00102	CcSEcCtD
Valganciclovir—Paraesthesia—Dexamethasone—psoriatic arthritis	0.00102	0.00102	CcSEcCtD
Valganciclovir—Discomfort—Prednisone—psoriatic arthritis	0.00102	0.00102	CcSEcCtD
Valganciclovir—Mental disorder—Methotrexate—psoriatic arthritis	0.00102	0.00102	CcSEcCtD
Valganciclovir—Malnutrition—Methotrexate—psoriatic arthritis	0.00102	0.00102	CcSEcCtD
Valganciclovir—Hypersensitivity—Prednisolone—psoriatic arthritis	0.00101	0.00101	CcSEcCtD
Valganciclovir—Dyspepsia—Betamethasone—psoriatic arthritis	0.001	0.001	CcSEcCtD
Valganciclovir—Dyspepsia—Dexamethasone—psoriatic arthritis	0.001	0.001	CcSEcCtD
Valganciclovir—Urticaria—Triamcinolone—psoriatic arthritis	0.000999	0.000999	CcSEcCtD
Valganciclovir—Urticaria—Methylprednisolone—psoriatic arthritis	0.000996	0.000996	CcSEcCtD
Valganciclovir—Dysgeusia—Methotrexate—psoriatic arthritis	0.000996	0.000996	CcSEcCtD
Valganciclovir—Body temperature increased—Triamcinolone—psoriatic arthritis	0.000994	0.000994	CcSEcCtD
Valganciclovir—Oedema—Prednisone—psoriatic arthritis	0.000993	0.000993	CcSEcCtD
Valganciclovir—Anaphylactic shock—Prednisone—psoriatic arthritis	0.000993	0.000993	CcSEcCtD
Valganciclovir—Abdominal pain—Methylprednisolone—psoriatic arthritis	0.000992	0.000992	CcSEcCtD
Valganciclovir—Decreased appetite—Dexamethasone—psoriatic arthritis	0.000992	0.000992	CcSEcCtD
Valganciclovir—Decreased appetite—Betamethasone—psoriatic arthritis	0.000992	0.000992	CcSEcCtD
Valganciclovir—Infection—Prednisone—psoriatic arthritis	0.000987	0.000987	CcSEcCtD
Valganciclovir—Gastrointestinal disorder—Dexamethasone—psoriatic arthritis	0.000985	0.000985	CcSEcCtD
Valganciclovir—Gastrointestinal disorder—Betamethasone—psoriatic arthritis	0.000985	0.000985	CcSEcCtD
Valganciclovir—Back pain—Methotrexate—psoriatic arthritis	0.000984	0.000984	CcSEcCtD
Valganciclovir—Fatigue—Dexamethasone—psoriatic arthritis	0.000983	0.000983	CcSEcCtD
Valganciclovir—Fatigue—Betamethasone—psoriatic arthritis	0.000983	0.000983	CcSEcCtD
Valganciclovir—Pain—Dexamethasone—psoriatic arthritis	0.000975	0.000975	CcSEcCtD
Valganciclovir—Pain—Betamethasone—psoriatic arthritis	0.000975	0.000975	CcSEcCtD
Valganciclovir—Nervous system disorder—Prednisone—psoriatic arthritis	0.000974	0.000974	CcSEcCtD
Valganciclovir—Tachycardia—Prednisone—psoriatic arthritis	0.000969	0.000969	CcSEcCtD
Valganciclovir—Skin disorder—Prednisone—psoriatic arthritis	0.000965	0.000965	CcSEcCtD
Valganciclovir—Hyperhidrosis—Prednisone—psoriatic arthritis	0.00096	0.00096	CcSEcCtD
Valganciclovir—Vision blurred—Methotrexate—psoriatic arthritis	0.000959	0.000959	CcSEcCtD
Valganciclovir—Anorexia—Prednisone—psoriatic arthritis	0.000947	0.000947	CcSEcCtD
Valganciclovir—Ill-defined disorder—Methotrexate—psoriatic arthritis	0.000944	0.000944	CcSEcCtD
Valganciclovir—Anaemia—Methotrexate—psoriatic arthritis	0.00094	0.00094	CcSEcCtD
Valganciclovir—Feeling abnormal—Betamethasone—psoriatic arthritis	0.00094	0.00094	CcSEcCtD
Valganciclovir—Feeling abnormal—Dexamethasone—psoriatic arthritis	0.00094	0.00094	CcSEcCtD
Valganciclovir—Gastrointestinal pain—Betamethasone—psoriatic arthritis	0.000933	0.000933	CcSEcCtD
Valganciclovir—Gastrointestinal pain—Dexamethasone—psoriatic arthritis	0.000933	0.000933	CcSEcCtD
Valganciclovir—Hypersensitivity—Triamcinolone—psoriatic arthritis	0.000926	0.000926	CcSEcCtD
Valganciclovir—Hypersensitivity—Methylprednisolone—psoriatic arthritis	0.000924	0.000924	CcSEcCtD
Valganciclovir—Malaise—Methotrexate—psoriatic arthritis	0.000917	0.000917	CcSEcCtD
Valganciclovir—Vertigo—Methotrexate—psoriatic arthritis	0.000914	0.000914	CcSEcCtD
Valganciclovir—Leukopenia—Methotrexate—psoriatic arthritis	0.000911	0.000911	CcSEcCtD
Valganciclovir—Urticaria—Dexamethasone—psoriatic arthritis	0.000906	0.000906	CcSEcCtD
Valganciclovir—Urticaria—Betamethasone—psoriatic arthritis	0.000906	0.000906	CcSEcCtD
Valganciclovir—Musculoskeletal discomfort—Prednisone—psoriatic arthritis	0.000905	0.000905	CcSEcCtD
Valganciclovir—Dizziness—Prednisolone—psoriatic arthritis	0.000904	0.000904	CcSEcCtD
Valganciclovir—Asthenia—Triamcinolone—psoriatic arthritis	0.000902	0.000902	CcSEcCtD
Valganciclovir—Abdominal pain—Dexamethasone—psoriatic arthritis	0.000902	0.000902	CcSEcCtD
Valganciclovir—Abdominal pain—Betamethasone—psoriatic arthritis	0.000902	0.000902	CcSEcCtD
Valganciclovir—Body temperature increased—Betamethasone—psoriatic arthritis	0.000902	0.000902	CcSEcCtD
Valganciclovir—Body temperature increased—Dexamethasone—psoriatic arthritis	0.000902	0.000902	CcSEcCtD
Valganciclovir—Asthenia—Methylprednisolone—psoriatic arthritis	0.0009	0.0009	CcSEcCtD
Valganciclovir—Insomnia—Prednisone—psoriatic arthritis	0.000898	0.000898	CcSEcCtD
Valganciclovir—Paraesthesia—Prednisone—psoriatic arthritis	0.000892	0.000892	CcSEcCtD
Valganciclovir—Pruritus—Triamcinolone—psoriatic arthritis	0.000889	0.000889	CcSEcCtD
Valganciclovir—Cough—Methotrexate—psoriatic arthritis	0.000888	0.000888	CcSEcCtD
Valganciclovir—Pruritus—Methylprednisolone—psoriatic arthritis	0.000887	0.000887	CcSEcCtD
Valganciclovir—Convulsion—Methotrexate—psoriatic arthritis	0.000881	0.000881	CcSEcCtD
Valganciclovir—Dyspepsia—Prednisone—psoriatic arthritis	0.000874	0.000874	CcSEcCtD
Valganciclovir—Arthralgia—Methotrexate—psoriatic arthritis	0.000866	0.000866	CcSEcCtD
Valganciclovir—Decreased appetite—Prednisone—psoriatic arthritis	0.000864	0.000864	CcSEcCtD
Valganciclovir—Dermatitis—Prednisolone—psoriatic arthritis	0.000861	0.000861	CcSEcCtD
Valganciclovir—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriatic arthritis	0.00086	0.00086	CcSEcCtD
Valganciclovir—Diarrhoea—Methylprednisolone—psoriatic arthritis	0.000858	0.000858	CcSEcCtD
Valganciclovir—Fatigue—Prednisone—psoriatic arthritis	0.000856	0.000856	CcSEcCtD
Valganciclovir—Headache—Prednisolone—psoriatic arthritis	0.000856	0.000856	CcSEcCtD
Valganciclovir—Discomfort—Methotrexate—psoriatic arthritis	0.000856	0.000856	CcSEcCtD
Valganciclovir—Constipation—Prednisone—psoriatic arthritis	0.000849	0.000849	CcSEcCtD
Valganciclovir—Confusional state—Methotrexate—psoriatic arthritis	0.000837	0.000837	CcSEcCtD
Valganciclovir—Dizziness—Triamcinolone—psoriatic arthritis	0.000831	0.000831	CcSEcCtD
Valganciclovir—Anaphylactic shock—Methotrexate—psoriatic arthritis	0.00083	0.00083	CcSEcCtD
Valganciclovir—Dizziness—Methylprednisolone—psoriatic arthritis	0.000829	0.000829	CcSEcCtD
Valganciclovir—Infection—Methotrexate—psoriatic arthritis	0.000825	0.000825	CcSEcCtD
Valganciclovir—Feeling abnormal—Prednisone—psoriatic arthritis	0.000819	0.000819	CcSEcCtD
Valganciclovir—Asthenia—Dexamethasone—psoriatic arthritis	0.000818	0.000818	CcSEcCtD
Valganciclovir—Asthenia—Betamethasone—psoriatic arthritis	0.000818	0.000818	CcSEcCtD
Valganciclovir—Nervous system disorder—Methotrexate—psoriatic arthritis	0.000814	0.000814	CcSEcCtD
Valganciclovir—Thrombocytopenia—Methotrexate—psoriatic arthritis	0.000813	0.000813	CcSEcCtD
Valganciclovir—Gastrointestinal pain—Prednisone—psoriatic arthritis	0.000812	0.000812	CcSEcCtD
Valganciclovir—Nausea—Prednisolone—psoriatic arthritis	0.000812	0.000812	CcSEcCtD
Valganciclovir—Pruritus—Dexamethasone—psoriatic arthritis	0.000807	0.000807	CcSEcCtD
Valganciclovir—Pruritus—Betamethasone—psoriatic arthritis	0.000807	0.000807	CcSEcCtD
Valganciclovir—Skin disorder—Methotrexate—psoriatic arthritis	0.000806	0.000806	CcSEcCtD
Valganciclovir—Hyperhidrosis—Methotrexate—psoriatic arthritis	0.000803	0.000803	CcSEcCtD
Valganciclovir—Vomiting—Triamcinolone—psoriatic arthritis	0.000799	0.000799	CcSEcCtD
Valganciclovir—Vomiting—Methylprednisolone—psoriatic arthritis	0.000798	0.000798	CcSEcCtD
Valganciclovir—Dermatitis—Triamcinolone—psoriatic arthritis	0.000792	0.000792	CcSEcCtD
Valganciclovir—Anorexia—Methotrexate—psoriatic arthritis	0.000791	0.000791	CcSEcCtD
Valganciclovir—Dermatitis—Methylprednisolone—psoriatic arthritis	0.00079	0.00079	CcSEcCtD
Valganciclovir—Urticaria—Prednisone—psoriatic arthritis	0.000789	0.000789	CcSEcCtD
Valganciclovir—Headache—Triamcinolone—psoriatic arthritis	0.000788	0.000788	CcSEcCtD
Valganciclovir—Headache—Methylprednisolone—psoriatic arthritis	0.000786	0.000786	CcSEcCtD
Valganciclovir—Body temperature increased—Prednisone—psoriatic arthritis	0.000785	0.000785	CcSEcCtD
Valganciclovir—Abdominal pain—Prednisone—psoriatic arthritis	0.000785	0.000785	CcSEcCtD
Valganciclovir—Diarrhoea—Betamethasone—psoriatic arthritis	0.00078	0.00078	CcSEcCtD
Valganciclovir—Diarrhoea—Dexamethasone—psoriatic arthritis	0.00078	0.00078	CcSEcCtD
Valganciclovir—Hypotension—Methotrexate—psoriatic arthritis	0.000776	0.000776	CcSEcCtD
Valganciclovir—Musculoskeletal discomfort—Methotrexate—psoriatic arthritis	0.000756	0.000756	CcSEcCtD
Valganciclovir—Dizziness—Betamethasone—psoriatic arthritis	0.000754	0.000754	CcSEcCtD
Valganciclovir—Dizziness—Dexamethasone—psoriatic arthritis	0.000754	0.000754	CcSEcCtD
Valganciclovir—Insomnia—Methotrexate—psoriatic arthritis	0.000751	0.000751	CcSEcCtD
Valganciclovir—Nausea—Triamcinolone—psoriatic arthritis	0.000747	0.000747	CcSEcCtD
Valganciclovir—Paraesthesia—Methotrexate—psoriatic arthritis	0.000745	0.000745	CcSEcCtD
Valganciclovir—Nausea—Methylprednisolone—psoriatic arthritis	0.000745	0.000745	CcSEcCtD
Valganciclovir—Dyspnoea—Methotrexate—psoriatic arthritis	0.00074	0.00074	CcSEcCtD
Valganciclovir—Somnolence—Methotrexate—psoriatic arthritis	0.000738	0.000738	CcSEcCtD
Valganciclovir—Hypersensitivity—Prednisone—psoriatic arthritis	0.000732	0.000732	CcSEcCtD
Valganciclovir—Dyspepsia—Methotrexate—psoriatic arthritis	0.000731	0.000731	CcSEcCtD
Valganciclovir—Vomiting—Betamethasone—psoriatic arthritis	0.000725	0.000725	CcSEcCtD
Valganciclovir—Vomiting—Dexamethasone—psoriatic arthritis	0.000725	0.000725	CcSEcCtD
Valganciclovir—Decreased appetite—Methotrexate—psoriatic arthritis	0.000722	0.000722	CcSEcCtD
Valganciclovir—Dermatitis—Dexamethasone—psoriatic arthritis	0.000719	0.000719	CcSEcCtD
Valganciclovir—Dermatitis—Betamethasone—psoriatic arthritis	0.000719	0.000719	CcSEcCtD
Valganciclovir—Gastrointestinal disorder—Methotrexate—psoriatic arthritis	0.000717	0.000717	CcSEcCtD
Valganciclovir—Fatigue—Methotrexate—psoriatic arthritis	0.000716	0.000716	CcSEcCtD
Valganciclovir—Headache—Betamethasone—psoriatic arthritis	0.000715	0.000715	CcSEcCtD
Valganciclovir—Headache—Dexamethasone—psoriatic arthritis	0.000715	0.000715	CcSEcCtD
Valganciclovir—Asthenia—Prednisone—psoriatic arthritis	0.000713	0.000713	CcSEcCtD
Valganciclovir—Pain—Methotrexate—psoriatic arthritis	0.00071	0.00071	CcSEcCtD
Valganciclovir—Pruritus—Prednisone—psoriatic arthritis	0.000703	0.000703	CcSEcCtD
Valganciclovir—Feeling abnormal—Methotrexate—psoriatic arthritis	0.000684	0.000684	CcSEcCtD
Valganciclovir—Diarrhoea—Prednisone—psoriatic arthritis	0.00068	0.00068	CcSEcCtD
Valganciclovir—Gastrointestinal pain—Methotrexate—psoriatic arthritis	0.000679	0.000679	CcSEcCtD
Valganciclovir—Nausea—Dexamethasone—psoriatic arthritis	0.000678	0.000678	CcSEcCtD
Valganciclovir—Nausea—Betamethasone—psoriatic arthritis	0.000678	0.000678	CcSEcCtD
Valganciclovir—Urticaria—Methotrexate—psoriatic arthritis	0.00066	0.00066	CcSEcCtD
Valganciclovir—Dizziness—Prednisone—psoriatic arthritis	0.000657	0.000657	CcSEcCtD
Valganciclovir—Abdominal pain—Methotrexate—psoriatic arthritis	0.000656	0.000656	CcSEcCtD
Valganciclovir—Body temperature increased—Methotrexate—psoriatic arthritis	0.000656	0.000656	CcSEcCtD
Valganciclovir—Vomiting—Prednisone—psoriatic arthritis	0.000632	0.000632	CcSEcCtD
Valganciclovir—Dermatitis—Prednisone—psoriatic arthritis	0.000626	0.000626	CcSEcCtD
Valganciclovir—Headache—Prednisone—psoriatic arthritis	0.000622	0.000622	CcSEcCtD
Valganciclovir—Hypersensitivity—Methotrexate—psoriatic arthritis	0.000612	0.000612	CcSEcCtD
Valganciclovir—Asthenia—Methotrexate—psoriatic arthritis	0.000596	0.000596	CcSEcCtD
Valganciclovir—Nausea—Prednisone—psoriatic arthritis	0.00059	0.00059	CcSEcCtD
Valganciclovir—Pruritus—Methotrexate—psoriatic arthritis	0.000587	0.000587	CcSEcCtD
Valganciclovir—Diarrhoea—Methotrexate—psoriatic arthritis	0.000568	0.000568	CcSEcCtD
Valganciclovir—Dizziness—Methotrexate—psoriatic arthritis	0.000549	0.000549	CcSEcCtD
Valganciclovir—Vomiting—Methotrexate—psoriatic arthritis	0.000528	0.000528	CcSEcCtD
Valganciclovir—Dermatitis—Methotrexate—psoriatic arthritis	0.000523	0.000523	CcSEcCtD
Valganciclovir—Headache—Methotrexate—psoriatic arthritis	0.00052	0.00052	CcSEcCtD
Valganciclovir—Nausea—Methotrexate—psoriatic arthritis	0.000493	0.000493	CcSEcCtD
